These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24012959)

  • 1. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
    Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y; Weinman EJ; Dai JL
    Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
    Takahashi Y; Morales FC; Kreimann EL; Georgescu MM
    EMBO J; 2006 Feb; 25(4):910-20. PubMed ID: 16456542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN.
    Zheng J; Dai Y; Yang Z; Yang L; Peng Z; Meng R; Xiong Y; He J
    Oncol Rep; 2016 Jan; 35(1):530-7. PubMed ID: 26531778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y; Wang L; Dai JL
    Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM
    Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
    Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
    Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
    Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
    Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
    Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J
    Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
    Morales FC; Takahashi Y; Momin S; Adams H; Chen X; Georgescu MM
    Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
    Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.
    Kuang YQ; Pang W; Zheng YT; Dupré DJ
    Eur J Immunol; 2012 Feb; 42(2):299-310. PubMed ID: 22028271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
    Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
    Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
    Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
    Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
    Wang JQ; Qin F; Zhu L
    J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHERF1 regulates actin cytoskeleton organization through modulation of α-actinin-4 stability.
    Sun L; Zheng J; Wang Q; Song R; Liu H; Meng R; Tao T; Si Y; Jiang W; He J
    FASEB J; 2016 Feb; 30(2):578-89. PubMed ID: 26432781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.
    Bellizzi A; Mangia A; Malfettone A; Cardone RA; Simone G; Reshkin SJ; Paradiso A
    Histopathology; 2011 Jun; 58(7):1086-95. PubMed ID: 21707710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.